Details for Patent: 8,361,488

« Back to Dashboard

Which drugs does patent 8,361,488 protect, and when does it expire?

Patent 8,361,488 protects RAYALDEE and is included in one NDA.

This patent has fifty-four patent family members in sixteen countries.

Summary for Patent: 8,361,488

Title:	Methods and compositions for controlled release oral dosage of a vitamin D compound
Abstract:	A stable, controlled release formulation for oral dosing of vitamin D compounds is disclosed. The formulation is prepared by incorporating one or more vitamin D compounds into a solid or semi-solid mixture of waxy materials. Oral dosage forms can be prepared by melt-blending the components described herein and filling gelatin capsules with the formulation.
Inventor(s):	Charles W. Bishop, Samir P. Tabash, Sammy Asiamah Agudoawu, Jay A. White, Keith H. Crawford, Eric J. Messner, P. Martin Petkovich
Assignee:	Eirgen Pharma Ltd
Application Number:	US12/109,983
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound; Dosage form;

Drugs Protected by US Patent 8,361,488

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Eirgen	RAYALDEE	calcifediol	CAPSULE, EXTENDED RELEASE;ORAL	208010-001	Jun 17, 2016		RX	Yes	Yes	8,361,488		Y

International Family Members for US Patent 8,361,488

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	2481400		301085	Netherlands
European Patent Office	2481400		122020000079	Germany
European Patent Office	2481400		CA 2020 00059	Denmark